E
Cogent Biosciences, Inc. COGT
$12.23 $0.443.73% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -2.14% -5.98% 3.83% -19.82% -1.03%
Total Depreciation and Amortization 1.67% 2.71% 1.00% 1.57% 1.31%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 10.41% 22.79% 77.32% -66.98% 57.47%
Change in Net Operating Assets 266.14% -316.98% -108.44% 419.99% 179.41%
Cash from Operations 18.00% -9.80% -16.53% -21.74% 18.71%
Capital Expenditure 76.05% -629.33% 73.21% -89.19% -111.43%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -87.07% 13.25% 2.12% 171.58% -7,683.21%
Cash from Investing -87.16% 12.50% 2.47% 171.12% -8,205.84%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -97.18% 19,717.46% -79.81% -94.50% -94.70%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 100.00% --
Cash from Financing 89.13% 95,938.46% -95.83% 343.75% -100.12%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -94.27% 2,385.54% -87.31% 106.92% -178.48%